Advertisement

Journal of Autism and Developmental Disorders

, Volume 44, Issue 10, pp 2558–2567 | Cite as

In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder

  • Nicole B. Gidaya
  • Brian K. Lee
  • Igor Burstyn
  • Michael Yudell
  • Erik L. Mortensen
  • Craig J. Newschaffer
Original Paper

Abstract

We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark’s health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child’s risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.

Keywords

Autism spectrum disorders Selective serotonin reuptake inhibitors Pregnancy Depression 

Notes

Acknowledgments

We thank Karyn Heavner, Ph.D., for assisting with data management, and implementation of Monte Carlo simulations. Fees to access Denmark’s national’s registers were funded by Drexel University Department of Epidemiology and Biostatistics (Dr. Newschaffer). Dr. Gidaya’s travel was funded in part through a travel award through Drexel University.

Conflict of interest

All authors and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.

References

  1. Anderson, G. M., Czarkowski, K., Ravski, N., & Epperson, C. N. (2004). Platelet serotonin in newborns and infants: Ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors. Pediatric Research, 56, 418–422.PubMedCrossRefGoogle Scholar
  2. Anderson, G. M., et al. (1987). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28, 885–900.PubMedCrossRefGoogle Scholar
  3. Andrade, S. E., et al. (2008). Use of antidepressant medications during pregnancy: A multisite study. American Journal of Obstetrics and Gynecology, 198(194), e1–e5.PubMedGoogle Scholar
  4. Atladottir, H. O., et al. (2009). Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics, 124, 687–694.PubMedCrossRefGoogle Scholar
  5. Atladottir, H. O., et al. (2010). Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. Journal of Autism and Developmental Disorders, 40, 1423–1430.PubMedCrossRefGoogle Scholar
  6. Bakker, M. K., Kerstjens-Frederikse, W. S., Buys, C. H., de Walle, H. E., & de Jong-van den Berg, L. T. (2010). First-trimester use of paroxetine and congenital heart defects: A population-based case–control study. Birth Defects Research Part A: Clinical and Molecular Teratology, 88, 94–100.Google Scholar
  7. Bakker, M. K., Kolling, P., van den Berg, P. B., de Walle, H. E., & de Jong van den Berg, L. T. (2008). Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British Journal of Clinical Pharmacology, 65, 600–606.PubMedCrossRefPubMedCentralGoogle Scholar
  8. Bodnar, L. M., Siega-Riz, A. M., Simhan, H. N., Diesel, J. C., & Abrams, B. (2010). The impact of exposure misclassification on associations between prepregnancy BMI and adverse pregnancy outcomes. Obesity (Silver Spring), 18, 2184–2190.CrossRefGoogle Scholar
  9. Bolton, P. F., Pickles, A., Murphy, M., & Rutter, M. (1998). Autism, affective and other psychiatric disorders: Patterns of familial aggregation. Psychological Medicine, 28, 385–395.PubMedCrossRefGoogle Scholar
  10. Bonnin, A., & Levitt, P. (2011). Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience, 197, 1–7.PubMedCrossRefPubMedCentralGoogle Scholar
  11. Borue, X., Chen, J., & Condron, B. G. (2007). Developmental effects of SSRIs: Lessons learned from animal studies. International Journal of Developmental Neuroscience, 25, 341–347.PubMedCrossRefPubMedCentralGoogle Scholar
  12. Brennan, P. A., Hammen, C., Andersen, M. J., Bor, W., Najman, J. M., & Williams, G. M. (2000). Chronicity, severity, and timing of maternal depressive symptoms: Relationships with child outcomes at age 5. Developmental Psychology, 36, 759–766.PubMedCrossRefGoogle Scholar
  13. Burstyn, I., Sithole, F., & Zwaigenbaum, L. (2010). Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada. Chronic Diseases in Canada, 30, 125–134.PubMedGoogle Scholar
  14. Caplan, H. L., Cogill, S. R., Alexandra, H., Robson, K. M., Katz, R., & Kumar, R. (1989). Maternal depression and the emotional development of the child. British Journal of Psychiatry, 154, 818–822.PubMedCrossRefGoogle Scholar
  15. Carter, A. S., Garrity-Rokous, F. E., Chazan-Cohen, R., Little, C., & Briggs-Gowan, M. J. (2001). Maternal depression and comorbidity: Predicting early parenting, attachment security, and toddler social–emotional problems and competencies. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 18–26.PubMedCrossRefGoogle Scholar
  16. Cook, E. H, Jr, Leventhal, B. L., & Freedman, D. X. (1988). Free serotonin in plasma: Autistic children and their first-degree relatives. Biological Psychiatry, 24, 488–491.PubMedCrossRefGoogle Scholar
  17. Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007). Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology, 196(544), e1–e5.Google Scholar
  18. Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Hendrick, V. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68, 1104–1112.PubMedCrossRefGoogle Scholar
  19. Daniels, J. L., et al. (2008). Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics, 121, e1357–e1362.PubMedCrossRefGoogle Scholar
  20. Deave, T., Heron, J., Evans, J., & Emond, A. (2008). The impact of maternal depression in pregnancy on early child development. BJOG, 115, 1043–1051.PubMedCrossRefGoogle Scholar
  21. Durkin, M. S., et al. (2010). Socioeconomic inequality in the prevalence of autism spectrum disorder: Evidence from a US cross-sectional study. PLoS One, 5, e11551.PubMedCrossRefPubMedCentralGoogle Scholar
  22. Evans, J., Heron, J., Francomb, H., Oke, S., & Golding, J. (2001). Cohort study of depressed mood during pregnancy and after childbirth. BMJ, 323, 257–260.PubMedCrossRefPubMedCentralGoogle Scholar
  23. Frisell, T., Oberg, S., Kuja-Halkola, R., & Sjolander, A. (2012). Sibling comparison designs: Bias from non-shared confounders and measurement error. Epidemiology, 23, 713–720.PubMedCrossRefGoogle Scholar
  24. Giarelli, E., et al. (2010). Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disability and Health Journal, 3, 107–116.PubMedCrossRefGoogle Scholar
  25. Gislason, G. H., et al. (2006). Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. European Heart Journal, 27, 1153–1158.PubMedCrossRefGoogle Scholar
  26. Hanley, J. A. (2001). A heuristic approach to the formulas for population attributable fraction. Journal of Epidemiology and Community Health, 55, 508–514.PubMedCrossRefPubMedCentralGoogle Scholar
  27. Hanley, G. E., Brain, U., & Oberlander, T. F. (2013). Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Human Development, 89, 519–524.PubMedCrossRefGoogle Scholar
  28. Huot, R. L., Brennan, P. A., Stowe, Z. N., Plotsky, P. M., & Walker, E. F. (2004). Negative affect in offspring of depressed mothers is predicted by infant cortisol levels at 6 months and maternal depression during pregnancy, but not postpartum. Annals of the New York Academy of Sciences, 1032, 234–236.PubMedCrossRefGoogle Scholar
  29. Hviid, A., Melbye, M., & Pasternak, B. (2013). Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. New England Journal of Medicine, 369, 2406–2415.PubMedCrossRefGoogle Scholar
  30. Jimenez-Solem, E., et al. (2012). Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: A nationwide cohort study. BMJ Open, 2, 1–9.Google Scholar
  31. Jimenez-Solem, E., et al. (2013). SSRI use during pregnancy and risk of stillbirth and neonatal mortality. American Journal of Psychiatry, 170, 299–304.PubMedCrossRefGoogle Scholar
  32. Jones, W., & Klin, A. (2009). Heterogeneity and homogeneity across the autism spectrum: The role of development. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 471–473.PubMedCrossRefGoogle Scholar
  33. Josefsson, A., Berg, G., Nordin, C., & Sydsjo, G. (2001). Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstetricia et Gynecologica Scandinavica, 80, 251–255.PubMedCrossRefGoogle Scholar
  34. Kaae, J., Boyd, H. A., Hansen, A. V., Wulf, H. C., Wohlfahrt, J., & Melbye, M. (2010). Photosensitizing medication use and risk of skin cancer. Cancer Epidemiology Biomarkers & Prevention, 19, 2942–2949.CrossRefGoogle Scholar
  35. Kanner, L. (1968). Autistic disturbances of affective contact. Acta Paedopsychiatr, 35, 100–136.PubMedGoogle Scholar
  36. Kieler, H., et al. (2012). Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries. BMJ, 344, d8012.PubMedCrossRefGoogle Scholar
  37. Lam, K. S., Aman, M. G., & Arnold, L. E. (2006). Neurochemical correlates of autistic disorder: A review of the literature. Research in Developmental Disabilities, 27, 254–289.PubMedCrossRefGoogle Scholar
  38. Larsson, H. J., et al. (2005). Risk factors for autism: Perinatal factors, parental psychiatric history, and socioeconomic status. American Journal of Epidemiology, 161, 916–925. (discussion 926–8).PubMedCrossRefGoogle Scholar
  39. Lauritsen, M. B., et al. (2010). Validity of childhood autism in the Danish Psychiatric Central Register: Findings from a cohort sample born 1990–1999. Journal of Autism and Developmental Disorders, 40, 139–148.PubMedCrossRefGoogle Scholar
  40. Lee, D., Majumdar, S. R., Lipton, H. L., Soumerai, S. B., Hennessy, S., & Davis, R. L. (2013). Special applications of pharmacoepidemiology. In B. L. Strom & S. E. Kimmel (Eds.), Textbook of pharmacoepidemiology (pp. 399–445). Philadelphia: Wiley.CrossRefGoogle Scholar
  41. Lin, D. Y., Psaty, B. M., & Kronmal, R. A. (1998). Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics, 54, 948–963.PubMedCrossRefGoogle Scholar
  42. Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010). Negative controls: A tool for detecting confounding and bias in observational studies. Epidemiology, 21, 383–388.PubMedCrossRefPubMedCentralGoogle Scholar
  43. Lund, N., Pedersen, L. H., & Henriksen, T. B. (2009). Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Archives of Pediatrics and Adolescent Medicine, 163, 949–954.PubMedCrossRefGoogle Scholar
  44. Maciag, D., et al. (2006). Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology, 31, 47–57.PubMedPubMedCentralGoogle Scholar
  45. Moth, G., Schiotz, P. O., & Vedsted, P. (2008). A Danish population-based cohort study of newly diagnosed asthmatic children’s care pathway: Adherence to guidelines. BMC Health Services Research, 8, 130.PubMedCrossRefPubMedCentralGoogle Scholar
  46. Olesen, C., Thrane, N., Nielsen, G. L., Sorensen, H. T., & Olsen, J. (2001). A population-based prescription study of asthma drugs during pregnancy: Changing the intensity of asthma therapy and perinatal outcomes. Respiration, 68, 256–261.PubMedCrossRefGoogle Scholar
  47. Olsen, L. R., Mortensen, E. L., & Bech, P. (2004). Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatrica Scandinavica, 109, 96–103.PubMedCrossRefGoogle Scholar
  48. Rai, D., Lee, B. K., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013). Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: Population based case–control study. BMJ, 346, f2059.PubMedCrossRefPubMedCentralGoogle Scholar
  49. Ramos, E., St-Andre, M., Rey, E., Oraichi, D., & Berard, A. (2008). Duration of antidepressant use during pregnancy and risk of major congenital malformations. British Journal of Psychiatry, 192, 344–350.PubMedCrossRefGoogle Scholar
  50. Rice, F., Jones, I., & Thapar, A. (2007). The impact of gestational stress and prenatal growth on emotional problems in offspring: A review. Acta Psychiatrica Scandinavica, 115, 171–183.PubMedCrossRefGoogle Scholar
  51. Schendel, D., & Bhasin, T. K. (2008). Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics, 121, 1155–1164.PubMedCrossRefGoogle Scholar
  52. Schernhammer, E., Hansen, J., Rugbjerg, K., Wermuth, L., & Ritz, B. (2011). Diabetes and the risk of developing Parkinson’s disease in Denmark. Diabetes Care, 34, 1102–1108.PubMedCrossRefPubMedCentralGoogle Scholar
  53. Sorensen, M. J., et al. (2013). Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clinical Epidemiology, 5, 449–459.PubMedCrossRefPubMedCentralGoogle Scholar
  54. Susser, E., Eide, M. G., & Begg, M. (2010). Invited commentary: The use of sibship studies to detect familial confounding. American Journal of Epidemiology, 172, 537–539.PubMedCrossRefGoogle Scholar
  55. Vorhees, C. V., Acuff-Smith, K. D., Schilling, M. A., Fisher, J. E., Moran, M. S., & Buelke-Sam, J. (1994). A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundamental and Applied Toxicology, 23, 194–205.PubMedCrossRefGoogle Scholar
  56. Weikum, W. M., Oberlander, T. F., Hensch, T. K., & Werker, J. F. (2012). Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proceedings of the National Academy of Sciences of the USA, 109(Suppl 2), 17221–17227.PubMedCrossRefPubMedCentralGoogle Scholar
  57. Whitaker-Azmitia, P. M. (2001). Serotonin and brain development: Role in human developmental diseases. Brain Research Bulletin, 56, 479–485.PubMedCrossRefGoogle Scholar
  58. Yudell, M., Tabor, H. K., Dawson, G., Rossi, J., Newschaffer, C. (2013). Priorities for autism spectrum disorders risk communication and ethics. Autism, 17(6), 701–722.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Nicole B. Gidaya
    • 1
  • Brian K. Lee
    • 1
  • Igor Burstyn
    • 1
  • Michael Yudell
    • 1
  • Erik L. Mortensen
    • 2
  • Craig J. Newschaffer
    • 3
  1. 1.Drexel University, School of Public Health, Nesbitt HallPhiladelphiaUSA
  2. 2.Institut for FolkesundhedsvidenskabUniversity of CopenhagenCopenhagen KDenmark
  3. 3.A.J. Drexel Autism InstituteDrexel UniversityPhiladelphiaUSA

Personalised recommendations